Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000076 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
48,522
Total Value
$651,037.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 13, 2026 | Exercise/Conversion | 6,349 | $1.08 | $6,856.92 | 82,489 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 13, 2026 | Exercise/Conversion | 3,542 | $10.20 | $36,128.40 | 86,031 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 13, 2026 | Exercise/Conversion | 4,167 | $14.25 | $59,379.75 | 90,198 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 13, 2026 | Sale | 14,058 | $26.54 | $373,086.67 | 76,140 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Sale | 6,348 | $27.66 | $175,585.68 | 69,792 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Apr 13, 2026 | Exercise/Conversion | 6,349 | $0.00 | $0.00 | 19,046 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Apr 13, 2026 | Exercise/Conversion | 3,542 | $0.00 | $0.00 | 120,417 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Apr 13, 2026 | Exercise/Conversion | 4,167 | $0.00 | $0.00 | 91,667 | Direct | โ | View Details |